Obesity-driven metabolic effects differ in ovarian vs endometrial cancer

被引：0
|
作者：
Tran, A. Q. M. [1 ]
Sullivan, S. A. [1 ]
Lee, D. [2 ]
Makowski, L. [1 ]
Bae-Jump, V. L. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Om Insight LCC, Durham, NC USA
来源：
GYNECOLOGIC ONCOLOGY | 2017年 / 145卷
关键词：
D O I：
10.1016/j.ygyno.2017.03.090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
62
引用
收藏
页码：34 / 35
页数：3
相关论文
共 50 条
  • [1] Reversal of obesity-driven aggressiveness of endometrial cancer by metformin
    Sullivan, S. A.
    Tran, A. M.
    Clark, L. H.
    Bateman, N. W.
    Hood, B. L.
    Conrads, T. P.
    Lee, D.
    Zhou, C.
    Makowski, L.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 21 - 22
  • [2] Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer
    Njoku, Kelechi
    Campbell, Amy E.
    Geary, Bethany
    MacKintosh, Michelle L.
    Derbyshire, Abigail E.
    Kitson, Sarah J.
    Sivalingam, Vanitha N.
    Pierce, Andrew
    Whetton, Anthony D.
    Crosbie, Emma J.
    CANCERS, 2021, 13 (04) : 1 - 25
  • [3] Drug repurposing of topiramate in obesity-driven endometrial cancer
    Tran, Arthur-Quan
    Sullivan, Stephanie A.
    Zhou, Chunxiao
    Kaufman, David
    Bae-Jump, Victoria
    CANCER RESEARCH, 2017, 77
  • [4] Obesity-driven endometrial cancer: is weight loss the answer?
    MacKintosh, M. L.
    Crosbie, E. J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 (07) : 791 - 794
  • [5] Reversal of obesity-driven aggressiveness of endometrial cancer by metformin
    Guo, Hui
    Kong, Weimin
    Zhang, Lu
    Han, Jianjun
    Clark, Leslie H.
    Yin, Yajie
    Fang, Ziwei
    Sun, Wenchuan
    Wang, Jiandong
    Gilliam, Timothy P.
    Lee, Douglas
    Makowski, Liza
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (10): : 2170 - 2193
  • [6] Orlistat as a novel targeted therapy for obesity-driven endometrial cancer
    Sullivan, Stephanie
    Tran, Arthur-Quan
    Wysham, Weiya
    Gehrig, Paola
    Zhou, Chunxiao
    Bae-Jump, Victoria
    CANCER RESEARCH, 2017, 77
  • [7] ONC201 has anti-tumorigenic effects in obesity-driven endometrial cancer
    Tucker, K.
    Staley, A.
    Pierce, S. R.
    Fan, Y.
    Yin, Y.
    Sun, W.
    Zhao, X.
    Zhang, Y.
    Lee, D.
    Prabhu, V.
    Zhou, C.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 49 - 49
  • [8] PD-1 inhibitor treatment impacts both immune and metabolic pathways in obesity-driven endometrial cancer
    Staley, A.
    Tucker, K.
    Fang, Z.
    Sun, W.
    Yin, Y.
    Zhang, Y.
    Lee, D.
    Zhou, C.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 48 - 48
  • [9] A presurgical window-of-opportunity study of metformin in obesity-driven endometrial cancer
    Sivalingam, Vanitha
    McVey, Rhona
    Gilmour, Kyle
    Ali, Saad
    Roberts, Chris
    Renehan, Andrew
    Kitchener, Henry
    Crosbie, Emma
    LANCET, 2015, 385 : 90 - 90
  • [10] Pre-surgical window study of metformin in obesity-driven endometrial cancer
    Sivalingam, V. N.
    McVey, R.
    Kitson, S.
    Gilmour, K.
    Ali, S.
    Roberts, C.
    Renehan, A. G.
    Kitchener, H.
    Crosbie, E. J.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 18 - 18
12345